Researchers demonstrated that left ventricular unloading with transcatheter aortic valve replacement is associated with acute improvements in right ventricular function and right ventricular-pulmonary artery coupling.
Subcutaneous implantable cardioverter-defibrillator is a feasible option not only in patients without structural but also in a selected patient collective with structural heart disease.
Implantation of the self-expanding Biovalve transcatheter heart valve for the treatment of severe aortic stenosis was deemed to be safe, with clinical outcomes similar to those of other first-generation devices designed for the same indication.
Multiphase assessment of the neo left ventricular outflow tract may be superior to end-systolic estimates to determine the risk for LVOT obstruction with transcatheter mitral valve replacement.
The rate of complications and in-hospital mortality was found to be high in patients undergoing transcutaneous lead extraction for implantable device-related infections.
Three-dimensional transesophageal echocardiography does not require contrast media, which may be particularly beneficial in patients with impaired renal function.
A novel voltage-independent high-density mapping display can identify the functional substrate for ventricular tachycardia during sinus rhythm and guide targeted ablation.
Endocardial left atrial appendage closure performed at high volume centers had the lowest in-hospital complications and 30-day readmissions, but with higher hospitalization costs.
This study adds to the understanding of the early complications associated with cardiovascular implantable electronic devices (CIEDs) and the institutional variability in the quality of CIED implantation.
A systematic review compared the safety and efficacy of prasugrel and ticagrelor in patients with ACS undergoing PCI.
